✦ LIBER ✦

Xp22.2-3 Loss of Heterozygosity Is Associated with Germline BRCA1 Mutation in Ovarian Cancer

✍ Scribed by Thomas E. Buekers; Thomas A. Lallas; Richard E. Buller

Book ID: 112248025
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 129 KB
Volume: 76
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1999.5713

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomic Instability Study on the Japanes

Genomic Instability Study on the Japanese Familial Ovarian Cancer without Germline Mutation of BRCA1 or BRCA2 by Loss of Heterozygosity Analysis

✍ Ikunosuke Tsuneki 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

**Objective and Methods:** In order to explore whether novel genes have been contributing to carcinogenesis of familial ovarian cancer in which no germline mutation of BRCA1 nor BRCA2 is found in the form of a tumor suppressor gene, we have attempted to perform loss of heterozygosity (LOH) analysis

Characteristics of small breast and/or o

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2

✍ Ligtenberg, M J L; Brink, G; Hageman, S; Looij, E Van der; Devilee, P; Wigbout, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Prevalence and Penetrance of Germline BR

Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer

✍ Harvey A. Risch; John R. McLaughlin; David E.C. Cole; Barry Rosen; Linda Bradley 📂 Article 📅 2001 🏛 American Society of Human Genetics 🌐 English ⚖ 122 KB

Association of BRCA1 and BRCA2 Mutations

Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer

✍ Yang, Da; Khan, Sofia; Sun, Yan; Hess, Kenneth; Shmulevich, Ilya; Sood, Anil K.; 📂 Article 📅 2011 🏛 American Medical Association 🌐 English ⚖ 486 KB

Intron variants of the p53 gene are asso

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

✍ Wang-Gohrke, S; Weikel, W; Risch, H; Vesprini, D; Abrahamson, J; Lerman, C; Godw 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Association of in vitro chemotherapy dru

Association of in vitro chemotherapy drug resistance assays in ovarian cancer patients with BRCA1/2 mutations

✍ Lee, J.; Menzin, A.W.; John, V.S.; Lovecchio, J.L.; Whyte, J.S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 101 KB